Robert Haselkorn to Enzyme Inhibitors
This is a "connection" page, showing publications Robert Haselkorn has written about Enzyme Inhibitors.
Connection Strength
0.219
-
Recombinant yeast screen for new inhibitors of human acetyl-CoA carboxylase 2 identifies potential drugs to treat obesity. Proc Natl Acad Sci U S A. 2010 May 18; 107(20):9093-8.
Score: 0.074
-
The carboxyltransferase activity of the apicoplast acetyl-CoA carboxylase of Toxoplasma gondii is the target of aryloxyphenoxypropionate inhibitors. J Biol Chem. 2002 Jun 28; 277(26):23208-15.
Score: 0.042
-
An isoleucine/leucine residue in the carboxyltransferase domain of acetyl-CoA carboxylase is critical for interaction with aryloxyphenoxypropionate and cyclohexanedione inhibitors. Proc Natl Acad Sci U S A. 2001 Jun 05; 98(12):6617-22.
Score: 0.040
-
Growth of Toxoplasma gondii is inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylase. Proc Natl Acad Sci U S A. 1999 Nov 09; 96(23):13387-92.
Score: 0.036
-
Characterization of toxin-producing cyanobacteria by using an oligonucleotide probe containing a tandemly repeated heptamer. J Bacteriol. 1995 Oct; 177(20):6021-6.
Score: 0.027